Curran Terrie bought ARQT
August 20, 2026 · Form 4 insider transaction
Curran Terrie bought 1,072 shares of Arcutis Biotherapeutics, Inc. at $7.51 per share, a transaction worth $8.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,072
Price
$7.51
Total value
$8.1K
InsiderCurran Terrie
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 20, 2026
Filing dateAugust 24, 2026
Shares owned after24,598
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.